Clinical Trials Logo

Recurrent Abortion clinical trials

View clinical trials related to Recurrent Abortion.

Filter by:
  • None
  • Page 1

NCT ID: NCT04326595 Not yet recruiting - Recurrent Abortion Clinical Trials

Histopathological Evaluation of Product of Conception in Sporadic and Recurrent Abortions

Start date: December 20, 2020
Phase: N/A
Study type: Interventional

1. To evaluate histopathological findings of products of conception in both sporadic and recurrent miscarriage. 2. To determine the prevalence of chronic histiocytic intervillositis in both sporadic and recurrent miscarriage.

NCT ID: NCT03475160 Completed - Recurrent Abortion Clinical Trials

Sildenafil Citrate and Recurrent Abortion

Start date: December 1, 2015
Phase: N/A
Study type: Interventional

Two groups of unexplained recurrent spontaneous abortion, each included 65 participants. scheduled randomly into; the study group received Sildenafil Citrate and Placebo group. The intervention started from day 21-23 of the cycle preceding spontaneous pregnancy and continued till the 12th-week of gestation. The primary outcome measure was the difference in the live birth between both groups. Secondary outcome measures were the differences between both groups regard pulsatility index (PI) and resistance index (RI), a number of take-home babies, the reported side-effects of treatment and the pregnancy-related complications.

NCT ID: NCT02457377 Completed - Recurrent Abortion Clinical Trials

Laparoscopic Transabdominal Cerclage: New Approach

Start date: January 2004
Phase: N/A
Study type: Interventional

A 5-mm non-absorbable Mersilene polyester suture, with adjacent partially straightened blunt needles, is introduced into the abdominal cavity through the 5-mm trocar. However, flattening the curvature of the needles, while introducing the tape into the abdomen, will eventually pose a challenge during placement of the stitch (the needles' curvatures guarantee that the tissue penetration is done away from the uterine vessels). To overcome this problem, the following method was devised. A one cm suprapubic incision is made on the abdomen with a scalpel short of the peritoneum. A needle holder loaded with the needle is pushed through the incision until the tip is seen inside the peritoneal cavity. A grasper from one of the flank ports receives the tip and the needle is delivered carefully (FIGURE 1). The rest of the tape is pulled until the blunt end of the other needle appears, to be delivered in the same way but in the reverse order. • Operative Steps The vesico-uterine peritoneum is opened using scissors & the urinary bladder is dissected downwards from the lower uterine segment to expose the uterine vessels anteriorly on both sides . Both needles are passed through the lower uterine tissue medial to uterine vessels on the right & left sides (from anterior to posterior) . Then, both needles are passed through the remaining cervical tissue medial to uterosacral ligaments towards the posterior vaginal fornix (on the right & left sides) guided by laparoscopic illumination . When the needles' blunt ends pierce the vaginal vault, the assistant pull them through the posterior vaginal fornix . After trimming of both needles, the Mersilene tape is tied tightly behind the intravaginal segment of the cervix with five knots & the ends of the stitch are trimmed. The vesico-uterine peritoneum is then reapproximated over the laparoscopic cerclage with a running (00) Monocryl suture that is tied intracorporeally.

NCT ID: NCT02088424 Not yet recruiting - Recurrent Abortion Clinical Trials

the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION

Start date: March 2014
Phase: N/A
Study type: Observational [Patient Registry]

THE INSULIN RESISTANCE IN RECURRENT ABORTION

NCT ID: NCT01976676 Completed - Recurrent Abortion Clinical Trials

Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion

Start date: April 2011
Phase: Phase 2/Phase 3
Study type: Interventional

Recent data indicates that 5 methyltetrahydrofolate (5MTHF) can reduce serum homocystein level more efficiently than folic acid. On the other hand, folic acid is currently an important part of treatment in idiopathic recurrent abortion. There is no study comparing the effectiveness of these supplements in the treatment of recurrent abortion. The aim of this study is to compare the efficiency of these two agents in the treatment of recurrent abortion. In this study, patients with idiopathic recurrent abortion, referring to Avicenna clinic will be randomly allocated into two groups of those taking either folic acid (5 mg) or 5 MTHF (5mg) from 8 weeks prior to conception until the 20th week of pregnancy. The serum level of folate, homocystein, and ongoing pregnancy will be analysed and compared in the two groups.

NCT ID: NCT01612065 Completed - Infertility Clinical Trials

Optimum Misoprostol Dose Prior to Office Hysteroscopy

Start date: June 2012
Phase: Phase 3
Study type: Interventional

Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.

NCT ID: NCT01051778 Completed - Recurrent Abortion Clinical Trials

Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome

Start date: June 2006
Phase: Phase 2
Study type: Interventional

The aim of this study is to compare the efficacy and safety of Low molecular weight heparin (LMWH) plus low dose aspirin (LDA) with unfractionated heparin(UFH) plus LDA in women with recurrent pregnancy loss associated with antiphospholipid syndrome (APS).